Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Laboratory tests using preparations of Ebola virus and other hemorrhagic fever viruses showed that the system has the sensitivity and specificity needed to provide a viable clinical assay. The team reported their results in a paper published September 25 in Nature Scientific Reports.
An outbreak of Ebola virus in West Africa has killed more than 11,000 people since 2014, with new cases occurring recently in Guinea and Sierra Leone. The current gold standard for Ebola virus detection relies on a method called polymerase chain reaction (PCR) to amplify the virus’s genetic material for detection. Because PCR works on DNA molecules and Ebola is an RNA virus, the reverse transcriptase enzyme is used to make DNA copies of the viral RNA prior to PCR amplification and detection.
“Compared to our system, PCR detection is more complex and requires a laboratory setting,” said senior author Holger Schmidt, the Kapany Professor of Optoelectronics at UC Santa Cruz. “We’re detecting the nucleic acids directly, and we achieve a comparable limit of detection to PCR and excellent specificity.”
In laboratory tests, the system provided sensitive detection of Ebola virus while giving no positive counts in tests with two related viruses, Sudan virus and Marburg virus. Testing with different concentrations of Ebola virus demonstrated accurate quantification of the virus over six orders of magnitude. Adding a “preconcentration” step during sample processing on the microfluidic chip extended the limit of detection well beyond that achieved by other chip-based approaches, covering a range comparable to PCR analysis.
“The measurements were taken at clinical concentrations covering the entire range of what would be seen in an infected person,” Schmidt said.
Schmidt’s lab at UC Santa Cruz worked with researchers at Brigham Young University and UC Berkeley to develop the system. Virologists at Texas Biomedical Research Institute in San Antonio prepared the viral samples for testing.
The system combines two small chips, a microfluidic chip for sample preparation and an optofluidic chip for optical detection. For over a decade, Schmidt and his collaborators have been developing optofluidic chip technology for optical analysis of single molecules as they pass through a tiny fluid-filled channel on the chip. The microfluidic chip for sample processing can be integrated as a second layer next to or on top of the optofluidic chip.
Schmidt’s lab designed and built the microfluidic chip in collaboration with coauthor Richard Mathies at UC Berkeley who pioneered this technology. It is made of a silicon-based polymer, polydimethylsiloxane (PDMS), and has microvalves and fluidic channels to transport the sample between nodes for various sample preparation steps. The targeted molecules–in this case, Ebola virus RNA–are isolated by binding to a matching sequence of synthetic DNA (called an oligonucleotide) attached to magnetic microbeads. The microbeads are collected with a magnet, nontarget biomolecules are washed off, and the bound targets are then released by heating, labeled with fluorescent markers, and transferred to the optofluidic chip for optical detection.
Schmidt noted that the team has not yet been able to test the system starting with raw blood samples. That will require additional sample preparation steps, and it will also have to be done in a biosafety level 4 facility.
Read more: Chip-based technology enables reliable direct detection of Ebola virus
The Latest on: Ebola detection
[google_news title=”” keyword=”Ebola detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Ebola detection
- Ebola's exponential growthon May 16, 2024 at 5:00 pm
Here are three bad things about Ebola. The “bodily fluids” that ... but it is still in an early stage of testing. Human volunteers are now being given the vaccine to check for unforeseen ...
- World churches' grouping and global health body commemorate 50 years of collaborationon May 15, 2024 at 2:48 pm
Faith and health are close companions globally and in Geneva, an international city where the World Council of Churches and the World Health Organization live cheek-by-jowl in the same sector.
- What's worse for disease spread: animal loss, climate change or urbanization?on May 15, 2024 at 12:08 pm
Scientists are looking at the ways humans change the planet-- and the impact that has on the spread of infectious disease. You might be surprised at some of their conclusions.
- NanoViricides Has Filed its Quarterly Reporton May 15, 2024 at 2:51 am
Additional information regarding the NanoViricides Platform Technology, and the NanoViricides Drug Pipeline can be found in our Annual Report filed with the SEC filed with the SEC on October 13, 2023.
- Lassa fever case in Paris: What you need to knowon May 13, 2024 at 11:00 am
A case of Lassa fever has been reported in Paris, France, sparking lurid warnings about the "horrific Ebola-like bug".
- RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035on May 6, 2024 at 12:00 am
The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's strong global ...
- Chinese scientists create mutant Ebola virus in labon May 5, 2024 at 5:00 pm
The surrogate virus and matched hamster EVD [Ebola virus disease] model will improve the security and economy of the research in the EBOV field,' the researchers wrote in the study. Testing infectious ...
- Joel Breman, Who Helped Stop an Ebola Outbreak in Africa, Dies at 87on April 21, 2024 at 5:00 pm
By Adam Nossiter Dr. Joel Breman, a specialist in infectious diseases who was a member of the original team that helped combat the Ebola virus in 1976, died on April 6 at his home in Chevy Chase ...
- Retrospective genomic characterization of the 2020 Ebola outbreakon April 18, 2024 at 5:00 pm
Most recently, APL researchers expanded its functionality, improving its ability to assist responders in future outbreaks by applying the algorithms to the Ebola virus as well as other diseases ...
- Ebola viruson May 29, 2022 at 4:42 pm
Kadiatou and Ibrahima, Ebola orphans from Guinea, share their experience of stigma and loss ten years since the outbreak. Some Ugandans have been attacking the government's efforts, even denying ...
via Bing News